Application Information

This drug has been submitted to the FDA under the reference 202365/001.

Names and composition

"SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE" is the commercial name of a drug composed of SITAGLIPTIN PHOSPHATE and METFORMIN HYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
202365/001 SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE TABLET/ORAL 50MG and 500MG
202365/002 SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE TABLET/ORAL 50MG and 1000MG
204591/001 SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE SITAGLIPTIN PHOSPHATE;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 50MG and 500MG
204591/002 SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE SITAGLIPTIN PHOSPHATE;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 50MG and 1000MG
204591/003 SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE SITAGLIPTIN PHOSPHATE;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 100MG and 1000MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
202365/001 SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE TABLET/ORAL 50MG and 500MG
202365/002 SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE TABLET/ORAL 50MG and 1000MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved